Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Mean Arterial Pressure (MAP) Calculator
Collaborate
About
EQOH
Careers
Contact Us
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
search
Join
FREE
This site is intended for healthcare professionals
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Mean Arterial Pressure (MAP) Calculator
Collaborate
About
EQOH
Careers
Contact Us
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
Join
FREE
Edition
European
US
Rheumatology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
TLR7/8 Inhibitor Reduces Cutaneous Disease Activity in SLE
May 2026
Researchers reported significant dose-dependent improvements in lupus skin disease activity with the oral TLR7/8 inhibitor enpatoran.
Read more
15 Dec 2025
SLE Linked to Reduced ICU Survival Through Renal Dysfunction
Critically ill patients with systemic lupus erythematosus show reduced ICU survival, driven largely by renal dysfunction, with glucocorticoids potentially mitigating mortality risk.
13 Dec 2025
Biologic Switching Beats TNF Cycling in Psoriatic Arthritis
Real-world data show switching to IL-17 inhibitors after TNF inhibitor failure improves treatment retention compared with TNF cycling in psoriatic arthritis.
5 Dec 2025
Kefir Shows Potential as a Natural Strategy for Osteoporosis Management
A new review highlights kefir-derived peptides, probiotics and kefiran as promising natural strategies for bone health and osteoporosis prevention.
3 Dec 2025
New Guideline Enhances Safe csDMARD Use Nationwide
BSR has published an updated guideline on the safe use of csDMARDs, introducing new evidence, paediatric guidance, and risk-adaptive monitoring across the full life course.
1 Dec 2025
Cardiac Involvement Common and Severe in Eosinophilic Granulomatosis with Polyangiitis (EGPA)
Cardiac involvement was found in 35% of patients with EGPA, with pericarditis, myocarditis, and coronary vasospasms driving worse disease activity and prognosis.
27 Nov 2025
Early Secukinumab Offers No Advantage Over Standard Psoriatic Arthritis Care
New study finds early use of secukinumab in psoriatic arthritis offers no significant advantage over standard step-up treatment after one year.
25 Nov 2025
BMI Not Linked to Distal Interphalangeal Joint Osteoarthritis in Rheumatoid Arthritis
Study finds body mass index does not affect incidence or progression of distal interphalangeal joint osteoarthritis in rheumatoid arthritis patients.
23 Nov 2025
Joint Hypermobility Linked to Proprioceptive Deficits but Not Reduced Strength
A new study shows joint hypermobility impairs proprioception but does not reduce strength or functional stability, highlighting the need for targeted neuromuscular training.
Loading posts...
« Previous
1
…
5
6
7
8
9
…
44
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View